The Prognostic and Predictive Value of DR-70 Immunoassay, A Novel Fibrin-Associated Biomarker, in Patients with Advanced Gastrointestinal Cancers
Aim:DR-70 is a newly developed immunoassay that detects fibrin degradation products in blood.We aimed to evaluate ability of DR-70 in monitoring treatment response in advanced gastrointestinal (GI) cancers.Materials and Methods:We prospectively enrolled patients with advanced GI cancers treated with different lines 7gm pravana of systemic therapies